Molina Healthcare (MOH) Price Target Cut to $91.00

Molina Healthcare (NYSE:MOH) had its target price lowered by Morgan Stanley from $94.00 to $91.00 in a report issued on Wednesday. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 24.23% from the stock’s current price.

MOH has been the subject of several other research reports. Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Molina Healthcare in a research note on Wednesday. Zacks Investment Research raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. ValuEngine raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Leerink Swann increased their price objective on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, January 9th. Finally, Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $72.50.

Shares of Molina Healthcare (MOH) traded down $2.21 during trading on Wednesday, hitting $73.25. 1,376,860 shares of the stock were exchanged, compared to its average volume of 1,464,112. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $93.98. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market cap of $4,250.00, a P/E ratio of -9.07, a PEG ratio of 0.91 and a beta of 1.10.

In other news, Director Garrey Carruthers sold 1,300 shares of the firm’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $75.66, for a total transaction of $98,358.00. Following the completion of the transaction, the director now owns 7,016 shares of the company’s stock, valued at $530,830.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John C. Molina sold 21,650 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $92.41, for a total transaction of $2,000,676.50. Following the transaction, the director now directly owns 414,151 shares of the company’s stock, valued at approximately $38,271,693.91. The disclosure for this sale can be found here. Insiders have sold 703,705 shares of company stock valued at $56,003,375 in the last ninety days. Insiders own 6.20% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in MOH. Iridian Asset Management LLC CT bought a new position in shares of Molina Healthcare during the fourth quarter valued at $128,179,000. Renaissance Technologies LLC increased its position in shares of Molina Healthcare by 53.5% during the fourth quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after buying an additional 751,800 shares during the period. Jana Partners LLC increased its position in shares of Molina Healthcare by 52.5% during the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after buying an additional 731,992 shares during the period. Tavio Capital LLC increased its position in shares of Molina Healthcare by 418.0% during the third quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock worth $36,937,000 after buying an additional 433,485 shares during the period. Finally, Victory Capital Management Inc. increased its position in shares of Molina Healthcare by 36.0% during the fourth quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock worth $121,953,000 after buying an additional 420,756 shares during the period. 96.22% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Molina Healthcare (MOH) Price Target Cut to $91.00” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/02/14/molina-healthcare-moh-price-target-cut-to-91-00.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply